CTX110

Serial Number 88296694
Registration 6760727
700

Registration Progress

Application Filed
Feb 11, 2019
Under Examination
Nov 12, 2019
Approved for Publication
Sep 17, 2019
Published for Opposition
Sep 17, 2019
Registered
Jun 14, 2022

Trademark Image

CTX110

Basic Information

Serial Number
88296694
Registration Number
6760727
Filing Date
February 11, 2019
Registration Date
June 14, 2022
Published for Opposition
September 17, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 14, 2022
Registration
Registered
Classes
005 042

Rights Holder

CRISPR Therapeutics AG

99
Address
Baarerstrasse 14
ZUG V8 6300
CH

Ownership History

CRISPR Therapeutics AG

Original Applicant
99
Basel CH

CRISPR Therapeutics AG

Owner at Publication
99
ZUG V8 CH

CRISPR Therapeutics AG

Original Registrant
99
ZUG V8 CH

Legal Representation

Attorney
Tiffany D. Gehrke

USPTO Deadlines

Next Deadline
904 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220614)
Due Date
June 14, 2028
Grace Period Ends
December 14, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

47 events
Date Code Type Description Documents
Jun 14, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 14, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 10, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 9, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 27, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 12, 2022 IUAF S USE AMENDMENT FILED Loading...
Jan 27, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 12, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 12, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 12, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 14, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 7, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 7, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 11, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 11, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 5, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 5, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Aug 5, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 5, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 11, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 11, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
May 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 12, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 17, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 17, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 28, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 13, 2019 ALIE A ASSIGNED TO LIE Loading...
Aug 6, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 2, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 1, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 1, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 26, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 26, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 24, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 5, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
First Use Anywhere: Jul 22, 2019
First Use in Commerce: Jul 22, 2019
Class 042
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
First Use Anywhere: Jul 22, 2019
First Use in Commerce: Jul 22, 2019

Classification

International Classes
005 042